Search for: "Illumina, Inc. " Results 141 - 160 of 170
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Aug 2010, 8:44 pm by Marie Louise
  Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging novelty:… [read post]
21 May 2007, 11:44 am
-based Affymetrix Inc. that were blocking NimbleGen’s ability to market its gene chips in the U.S. [read post]
5 Jan 2008, 6:00 am
Navy: (IP Law360),Crown Packaging - Summary judgment granted to Reexam Beverage Co finding patent infringement by Crown: (Delaware IP Law),eBay - District Court held that likelihood of confusion analysis is not limited to the goods or services for which mark was registered in Applied Information Sciences v eBay: (IP Law Observer),Global Patent Holdings - GPH files another patent infringement case regarding their JPEG on a website patent: (Troll … [read post]
9 Jun 2023, 6:30 am
Louis), on Tuesday, June 6, 2023 Tags: Conflicts of interest, Fairness review, Fiduciary duties, IPOs, Safe harbor, SPACs, statutory requirements Icahn-Illumina Contest: Board Accountability and the UPC Posted by Ele Klein and Brandon S. [read post]
3 Jun 2010, 5:35 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/   Highlights this week included: US: Sen Kerry introduces Angiomax PTE amendment to Tax Extenders Act of 2009 (FDA Law Blog)   General Nature Biotechnology and more anti-gene patenting myths (Patent Docs) Alice de Pastor’s SPC news 2009 (The SPC Blog) US: Sen Kerry introduces Angiomax PTE amendment to Tax Extenders Act of 2009 (FDA Law Blog) US: Blinded… [read post]
9 Jun 2023, 6:30 am
Louis), on Tuesday, June 6, 2023 Tags: Conflicts of interest, Fairness review, Fiduciary duties, IPOs, Safe harbor, SPACs, statutory requirements Icahn-Illumina Contest: Board Accountability and the UPC Posted by Ele Klein and Brandon S. [read post]
28 Dec 2007, 1:00 am
Rodriguez (Patry Copyright Blog),KSR and the doctrine of equivalents: (The Fire of Genius),PLI poll results - 68% say eliminate rule 56: (PLI),Design patents - controlling pendency: (Patently O),USPTO to halt weekly paper publication of USPTO Practice and Procedure Notices: (Patent Docs) AT&T - Vonage to settle with AT&T in patent infringement dispute: (Ars Technica),eBay - US District Court finds eBay intentionally… [read post]
9 Aug 2019, 3:05 am by Liz Dunshee
The companies included Illumina Inc. (37.7%), Simon Property Group Inc. (37.1%), American Water Works Company Inc. (37.0%), Duke Energy Corp. (35.8%), Wyndham Destinations (35.6%), American Tower Corp. (35%), Royal Caribbean Cruises Ltd. (34.5%), Wynn Resorts Ltd. (34.4%) CMS Energy Corp. (34.3%), Equinix Inc. (34.2%), DTE Energy Co. (33.6%), and J.B. [read post]
11 Jan 2008, 9:00 am
You can separately subscribe to the IP Think Tank Global week in Review at [feeds.feedburner.com]Highlights this week included: European Commission launches consultation on ‘Content Online in the Single Market': (IPKat), (Out-Law), (IPR Helpdesk), UK government launches consultation on copyright exceptions: (IPKat), (Michael Geist), (IMPACT), (Patry Copyright Blog), (Out-Law), (Ars Technica), (IP Law360), Cordis Corporation - US Court of Appeals… [read post]
26 Jan 2012, 7:14 am by Theo Francis
By contrast, the 8-K filed by Intermec Inc. [read post]
25 Jan 2024, 6:32 am by Daniel J. Gilman
It also succeeded in blocking the Illumina/Grail merger by partly winning in the 5th U.S. [read post]
1 Apr 2010, 3:04 am
MDCO launches another lawsuit against the PTO over Angiomax PTE (FDA Law Blog) Arzerra (Ofatumumab) – US: Biogen files patent infringement suit in S D California against Glaxosmithkline based on manufacture and sale of Arzerra (Patent Docs) Arzerra (Ofatumumab) – US: Genetech files counterclaims in declaratory judgment suit brought by GlaxoSmithKline (Patent Docs) Astelin (Azelastine) – US: District Court New Jersey: Patent infringement complaint following Para IV challenge: Meda… [read post]
22 Mar 2011, 4:21 pm by Marie Louise
Brownback’s 2010 version (FDA Law Blog) US: Effective March 28, 2011 – New safety reporting requirements for certain drug and biological products (FDA Law Blog) US: FDA issues new guidance on PDUFA user fee waivers, reductions, and refunds; guidance represents the culmination of 18 years of FDA experience (FDA Law Blog) US: Affymetrix files for correction of inventorship: Affymetrix v Illumina (Patent Docs) US: Hoffman-La Roche files for review and correction of patent term… [read post]
27 Apr 2023, 4:25 am by Barry Barnett
FTC. https://www.competitionpolicyinternational.com/illumina-granted-fast-track-appeal-of-ftc-order/? [read post]
13 Aug 2019, 6:03 am
PepsiCo, Inc. regarding whether use of another’s trademark in a marketing slogan is fair use. [read post]